1. | yainounoino79 | |
2. | chartsANDthangs | |
3. | TheSeykota | |
4. | tcsiew | |
5. | jaysinwaters |
1. | yainounoino79 | |
2. | chartsANDthangs | |
3. | TheSeykota | |
4. | tcsiew | |
5. | jaysinwaters |
1. | TheSeykota 02/07/2018 AstraZeneca and Sosei Group immuno-oncology collaboration is 'progressing well'; |
2. | jaysinwaters 03/05/2018 Receives EMA acceptance for regulatory submission for Forxiga |
3. | tcsiew 02/20/2018 Ionis Pharma licenses IONIS-AZ5-2.5Rx to AstraZeneca, will receive a $30 mln upfront payment |
4. | chartsANDthangs 05/11/2018 Provides update on GALATHEA Phase III trial for Fasenra today |
5. | TheSeykota 11/04/2017 I would trim my gains. |
6. | tcsiew 02/16/2018 These guys keep getting good news but nothing moves this stock |
7. | TheSeykota 02/05/2018 Huh?? Could have got close before today |
8. | chartsANDthangs 05/30/2018 Update on Terranova PIII trial for Fasenra in COPD; |
9. | yainounoino79 04/18/2018 Roche expands indication for cobas® EGFR Mutation Test v2 as a companion diagnostic with TAGRISSO® |
10. | chartsANDthangs 02/07/2018 Reports Brilinta significantly reduced CV events and coronary death beyond one year |